Highlights
NASDAQ: IMMP       Immutep Ltd ADR
Last Price Today's Change   Day's Range   Trading Volume
1.99   -0.023 (1.14%)  1.96 - 2.04  29,500

Overview

 
Avg Volume (4 weeks):86,605
4 Weeks Range:1.71 - 2.25
4 Weeks Price Volatility (%):
51.85%
52 Weeks Range:1.27 - 3.23
52 Weeks Price Volatility (%):
36.73%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Prima BioMed Ltd is a globally active biotechnology company developing immunotherapeutic products for cancer and autoimmune diseases. Its lead product is IMP321, which involves in clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives most of the revenue from the sale of the products.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers